Cargando…

Correction: EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937359/ http://dx.doi.org/10.1371/journal.pone.0091411

Ejemplares similares

EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
por: Gorsic, Lidija K., et al.
Publicado: (2013)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Correction: NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
por: Lin, Chao, et al.
Publicado: (2012)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
por: Subramanian, Nithya, et al.
Publicado: (2020)

Correction to: ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma
por: Peng, Hao, et al.
Publicado: (2022)

Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
por: Circu, Magdalena, et al.
Publicado: (2018)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
Publicado: (2018)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2023)

Correction: EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
por: Schneck, Helen, et al.
Publicado: (2016)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: Eps8 Regulates Axonal Filopodia in Hippocampal Neurons in Response to Brain-Derived Neurotrophic Factor (BDNF)
por: Menna, Elisabetta, et al.
Publicado: (2015)

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020)

Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity
por: Qin, Tao, et al.
Publicado: (2021)

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation
por: Khatri, Aaditya, et al.
Publicado: (2019)

Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
por: Barr, Martin P., et al.
Publicado: (2020)

Correction: d-Borneol enhances cisplatin sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis in non-small cell lung cancer cells and a murine xenograft model
por: Li, Jinxiu, et al.
Publicado: (2022)

Correction: The Endocytic Adaptor Eps15 Controls Marginal Zone B Cell Numbers
por: Pozzi, Benedetta, et al.
Publicado: (2013)

Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2020)

Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
por: Yan, Ying, et al.
Publicado: (2020)

Correction: A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia
por: Chen, Yiran, et al.
Publicado: (2022)

Correction: Selection and targeting of EpCAM protein by ssDNA aptamer
por: Alshaer, Walhan, et al.
Publicado: (2018)

Inhibiting the MCM8‐9 complex selectively sensitizes cancer cells to cisplatin and olaparib
por: Morii, Issay, et al.
Publicado: (2019)

Correction: Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells
por: Del Bello, Barbara, et al.
Publicado: (2013)

Correction: EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
Publicado: (2015)

Correction: Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023)

Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance
por: Xie, Longlong, et al.
Publicado: (2022)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

Inhibition of TIGAR Increases Exogenous p53 and Cisplatin Combination Sensitivity in Lung Cancer Cells by Regulating Glycolytic Flux
por: Fu, Jiaying, et al.
Publicado: (2022)

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022)

Correction: iASPP overexpression is associated with clinical outcome in spinal chordoma and influences cellular proliferation, invasion, and sensitivity to cisplatin in vitro
por: Ma, Yunlong, et al.
Publicado: (2023)

Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013)

Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
por: Zhao, Xinmin, et al.
Publicado: (2023)

Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
por: Fang, Chao, et al.
Publicado: (2021)

Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide
por: Nitta, Ryan T., et al.
Publicado: (2019)

Correction: Gualdani, R.; et al. Store-Operated Calcium Entry Contributes to Cisplatin-Induced Cell Death in Non-Small Cell Lung Carcinoma. Cancers 2019, 11, 430
por: Gualdani, Roberta, et al.
Publicado: (2020)

Correction: Infection with Soil-Transmitted Helminths Is Associated with Increased Insulin Sensitivity
por: Wiria, Aprilianto E., et al.
Publicado: (2015)

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
por: Osman, Abdel-Moneim M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ccfe6jfdb76naga5m972pph2bk